Prener Anne bought KROS
July 1, 2026 · Form 4 insider transaction
Prener Anne bought 14,870 shares of Keros Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,870
Price
$0.00
Total value
N/A
InsiderPrener Anne
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJuly 1, 2026
Filing dateJuly 6, 2026
Shares owned after14,870
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares subject to the option shall vest over a three-year period in equal quarterly installments with the first such vesting to occur on October 1, 2026, subject to the Reporting Person's continuous service through each such vesting date.